Cabot Corp (CBT) director Michelle Williams reports 2,298-share deferred award
Rhea-AI Filing Summary
Cabot Corporation director reports stock award under deferral plan. Director Michelle Elizabeth Williams acquired 2,298 shares of Cabot Corporation common stock on January 8, 2026, reported as an award at a price of $0 per share. Following this award, she beneficially owned 6,776 shares of Cabot common stock in total.
The filing notes that these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning the award is subject to the terms of that plan rather than delivered as immediately unrestricted shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,298 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Cabot Corp (CBT) report for Michelle Elizabeth Williams?
Cabot Corp reported that director Michelle Elizabeth Williams acquired 2,298 shares of Cabot common stock on January 8, 2026, at a reported price of $0 per share.
What is the nature of the stock award reported by Cabot Corp (CBT)?
The filing states that the 2,298 shares acquired by Michelle Elizabeth Williams have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
Was the Cabot Corp (CBT) insider transaction a purchase or an award?
The transaction is coded as A for acquisition and shows a $0 per share price, indicating it is a stock award rather than an open-market purchase.